BP Bunge chairman becomes president of BP in Brazil
Sep 09, 2024 14:06 CESTMay 24, 2012 - Danish biotech company Novozymes A/S (CPH:NZYM B) said yesterday it will supply enzyme technology for the first commercial cellulosic ethanol plant of Brazilian GraalBio and will expand its production capacity in the country.
GraalBio's facility will be located in the Brazilian state of Alagoas and will have an annual capacity of 82 million litres (22 million gallons) of cellulosic ethanol, produced from sugarcane bagasse and straw. Production start is scheduled for December 2013. Enzymes are a key element in cellulosic ethanol production as they turn the biomass into sugar that can be fermented into ethanol.
The biofuel industry in Brazil is scaling up, with expected doubled ethanol production by 2020, so Novozymes is considering to set up new enzyme manufacturing plants in the country to meet increased future demand. The company has already started searching for suitable locations.
Earlier this year, Novozymes launched Cellic CTec3, a new enzyme that helps cellulosic ethanol producers cut costs, while increasing yields. On the occasion of the introduction of Cellic Ctec3 in Latin America, Novozymes will organise a seminar on advanced biofuels in Sao Paolo on May 29.
BP Bunge chairman becomes president of BP in Brazil
Sep 09, 2024 14:06 CESTWorld set to install 593 GW of new solar in 2024 - Ember
Sep 19, 2024 13:28 CESTBrazil’s Rio Grande do Sul agrees green hydrogen pact
Sep 19, 2024 11:42 CESTArcelorMittal buys majority stake in Brazilian solar holding
Sep 19, 2024 9:29 CESTWeekly renewables M&A round-up (Sep 9-13)
Sep 13, 2024 17:19 CESTBrazil's RZK Energia partners up with Matrix for 38 MWp of DG solar
Sep 13, 2024 9:53 CEST